Lack of behavioural toxicity of mizolastine: a review of the clinical pharmacology studies

First‐generation H1 antihistamines were associated with major sedative side‐effects which were heavily disruptive to young active and aged patients when performing everyday activities. Mizolastine is a potent and selective H1‐receptor antagonist which slowly penetrates into the brain and thus lacks the sedative effects of earlier antihistamines.

[1]  P. Blondin,et al.  Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria , 1996, Allergy.

[2]  J. Bousquet,et al.  Efficacy and safety of mizolastine in seasonal allergic rhinitis. The Rhinase Study Group. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  H. Schoemaker,et al.  In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent. , 1995, Arzneimittel-Forschung.

[4]  B. Scatton,et al.  Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. , 1995, Arzneimittel-Forschung.

[5]  F. Simons.  The therapeutic index of newer H1‐receptor antagonists , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  I. Hindmarch,et al.  Psychometric aspects of antihistamines: A review , 1994 .

[7]  P. Rosenzweig,et al.  Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine. , 1992, Annals of allergy.

[8]  G. Bianchetti,et al.  CNS-pharmacodynamics and pharmacokinetics of the new non-sedative H1-antihistamine SL8S.0324 vs placebo and dimetinden in volunteers , 1990 .

[9]  J. Harmatz,et al.  Response of the elderly to psychotrophic drugs: predictable or idiosyncratic? , 1975, Psychopharmacology bulletin.

[10]  A. Irving,et al.  Methods for testing impairment of driving due to drugs , 2005, European Journal of Clinical Pharmacology.

[11]  I. Hindmarch,et al.  The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy volunteers , 2004, European Journal of Clinical Pharmacology.

[12]  B. Sexton,et al.  Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects , 2004, European Journal of Clinical Pharmacology.

[13]  P. Rosenzweig,et al.  Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers. , 1995, British journal of clinical pharmacology.

[14]  P. Granger,et al.  Mizolastine, a novel selective histamine H1 receptor antagonist: lack of sedative potential on the EEG in the rodent. , 1995, Neuropsychobiology.

[15]  P. Rosenzweig,et al.  Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjects , 1994, International clinical psychopharmacology.